KAVITA SHAH: Open Payments
NPI 1568509008 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 25 payments from 11 companies in 2025. Trend: 2023 $562 · 2024 $362 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $173 |
| E.R. Squibb & Sons, L.L.C. | 1 | $119 |
| Neurocrine BioSciences, Inc. | 4 | $109 |
| Alkermes, Inc. | 4 | $82 |
| ABBVIE INC. | 3 | $75 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| Lundbeck LLC | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Neuronetics, Inc. | 1 | $16 |
Products named: FANAPT, COBENFY, INGREZZA, VRAYLAR, ARISTADA, REXULTI, SPRAVATO, UZEDY.
Industry payments across IL — which companies pay providers there.
